BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15322173)

  • 21. Homeostasis of naive and memory CD4+ T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis.
    Jaleco S; Swainson L; Dardalhon V; Burjanadze M; Kinet S; Taylor N
    J Immunol; 2003 Jul; 171(1):61-8. PubMed ID: 12816983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12 / IL-4 stimulation in vitro.
    Niedbala W; Wei X; Liew FY
    Eur J Immunol; 2002 Feb; 32(2):341-7. PubMed ID: 11807773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27.
    Morishima N; Owaki T; Asakawa M; Kamiya S; Mizuguchi J; Yoshimoto T
    J Immunol; 2005 Aug; 175(3):1686-93. PubMed ID: 16034109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-15 promotes survival but not effector function differentiation of CD8+ TCRalphabeta+ intestinal intraepithelial lymphocytes.
    Lai YG; Gelfanov V; Gelfanova V; Kulik L; Chu CL; Jeng SW; Liao NS
    J Immunol; 1999 Dec; 163(11):5843-50. PubMed ID: 10570268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro.
    Alves NL; Hooibrink B; Arosa FA; van Lier RA
    Blood; 2003 Oct; 102(7):2541-6. PubMed ID: 12805064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin (IL)-2 and IL-15 have different effects on human natural killer lymphocytes.
    Pillet AH; Thèze J; Rose T
    Hum Immunol; 2011 Nov; 72(11):1013-7. PubMed ID: 21925225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of cytokine-driven functional differentiation of CD8 T cells by suppressor of cytokine signaling 1 controls autoimmunity and preserves their proliferative capacity toward foreign antigens.
    Ramanathan S; Dubois S; Gagnon J; Leblanc C; Mariathasan S; Ferbeyre G; Rottapel R; Ohashi PS; Ilangumaran S
    J Immunol; 2010 Jul; 185(1):357-66. PubMed ID: 20519645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice.
    Snow JW; Abraham N; Ma MC; Herndier BG; Pastuszak AW; Goldsmith MA
    J Immunol; 2003 Nov; 171(10):5042-50. PubMed ID: 14607901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functionally mature CD4 and CD8 TCRalphabeta cells are generated in OP9-DL1 cultures from human CD34+ hematopoietic cells.
    Van Coppernolle S; Verstichel G; Timmermans F; Velghe I; Vermijlen D; De Smedt M; Leclercq G; Plum J; Taghon T; Vandekerckhove B; Kerre T
    J Immunol; 2009 Oct; 183(8):4859-70. PubMed ID: 19801512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chimeric γc cytokine receptors confer cytokine independent engraftment of human T lymphocytes.
    Hunter MR; Prosser ME; Mahadev V; Wang X; Aguilar B; Brown CE; Forman SJ; Jensen MC
    Mol Immunol; 2013 Nov; 56(1-2):1-11. PubMed ID: 23628622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.
    Grange M; Verdeil G; Arnoux F; Griffon A; Spicuglia S; Maurizio J; Buferne M; Schmitt-Verhulst AM; Auphan-Anezin N
    J Immunol; 2013 Oct; 191(7):3712-24. PubMed ID: 24006458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-12-programmed long-term CD8+ T cell responses require STAT4.
    Li Q; Eppolito C; Odunsi K; Shrikant PA
    J Immunol; 2006 Dec; 177(11):7618-25. PubMed ID: 17114431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of cytokine differential induction of STAT complexes in primary human T and NK cells.
    Yu CR; Young HA; Ortaldo JR
    J Leukoc Biol; 1998 Aug; 64(2):245-58. PubMed ID: 9715265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disparate in vitro and in vivo requirements for IL-2 during antigen-independent CD8 T cell expansion.
    Wong P; Pamer EG
    J Immunol; 2004 Feb; 172(4):2171-6. PubMed ID: 14764683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cell receptor-induced calcineurin activation regulates T helper type 2 cell development by modifying the interleukin 4 receptor signaling complex.
    Yamashita M; Katsumata M; Iwashima M; Kimura M; Shimizu C; Kamata T; Shin T; Seki N; Suzuki S; Taniguchi M; Nakayama T
    J Exp Med; 2000 Jun; 191(11):1869-79. PubMed ID: 10839803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-4 influences the differentiation and the susceptibility to activation-induced cell death of human naive CD8+ T cells.
    Riou C; Dumont AR; Yassine-Diab B; Haddad EK; Sekaly RP
    Int Immunol; 2006 Jun; 18(6):827-35. PubMed ID: 16611649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of interleukin-2 receptor alpha (IL-2Ralpha) expression by interleukin-2: important role of the interleukin-2 receptor beta chain region between the two Stat5 docking sites.
    Imbert V; Rezzonico R; Reichenbach P; Nabholz M
    Eur Cytokine Netw; 2002; 13(3):331-9. PubMed ID: 12231477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
    Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
    J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-2 unresponsiveness in anergic CD4+ T cells is due to defective signaling through the common gamma-chain of the IL-2 receptor.
    Grundström S; Dohlsten M; Sundstedt A
    J Immunol; 2000 Feb; 164(3):1175-84. PubMed ID: 10640728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells.
    Rameil P; Lécine P; Ghysdael J; Gouilleux F; Kahn-Perlès B; Imbert J
    Oncogene; 2000 Apr; 19(17):2086-97. PubMed ID: 10815800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.